ukrain has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erdoğan, E; Genç, O; Savran, B; Yerlikaya, A | 1 |
Bezdeneznikh, N; Kudryavets, Y; Lykhova, O; Semesiuk, N; Skivka, L; Susak, Y; Trompak, O | 1 |
2 other study(ies) available for ukrain and B16 Melanoma
Article | Year |
---|---|
Anticancer agent ukrain and bortezomib combination is synergistic in 4T1 breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Berberine Alkaloids; Boronic Acids; Bortezomib; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Female; Humans; Melanoma, Experimental; Phenanthridines; Pyrazines | 2014 |
The effect of monotherapy and combined therapy with NSC-631570 (ukrain) on growth of low- and high-metastasizing B16 melanoma in mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Berberine Alkaloids; Cell Death; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phenanthridines; Random Allocation; Tumor Cells, Cultured | 2011 |